Lifting weights is the usual context for creatine research, so the question of what creatine does on its own gets less attention than it should. Two things are measured here: lean tissue mass by DXA scan, and short sprint or strength tests. The trials that gave creatine with no training programme are few, and they disagree.
The first-screen answer
| Trial | Who took part | Creatine dose | Length | Creatine alone against placebo |
|---|---|---|---|---|
| Chun et al., 2026 | 64 sedentary adults aged 45 to 65 (non-exercise stratum) | 2 × 5 g a day | 12 weeks | Lean tissue mass +1.1 kg (95% CI 0.2 to 2.0) at 12 weeks; placebo about zero |
| Bermon et al., 1998 | 32 adults aged 67 to 80, untrained arm | 20 g a day for five days, then 3 g a day | 52 days | No significant change in body composition or strength |
| Wiroth et al., 2001 | 14 sedentary men aged about 70 and 14 sedentary young men | 3 × 5 g a day for five days | 5 days | Peak sprint power +3.7% (older) and +2.0% (young) |
Read the table as three separate questions, not one. The 2026 trial asks whether creatine raises lean mass in people who do not exercise. The 1998 trial asks the same question in older adults at a lower maintenance dose. The 2001 trial asks whether a short loading course changes a sprint test.
The 2026 non-exercise stratum
The study is the most recent and the largest of the three designs that include a no-training group. Participants first chose whether to join a non-exercise stratum or an exercise-and-diet stratum, then were randomised within it to creatine or placebo. Lean tissue mass in the non-exercise creatine group rose by 0.99 kg at six weeks and 1.1 kg at 12 weeks, with 95% confidence intervals of 0.2 to 1.8 and 0.2 to 2.0. The placebo group's change was about zero. The authors report that creatine without exercise also increased strength; this page leaves that figure to the paper's supplementary tables because the summary does not state its size.
Three limits apply to this trial. Twelve weeks is short for a body-composition question. The strata were self-selected, so the non-exercise group is not a random sample of sedentary adults. And the senior author chairs the scientific advisory board of a creatine manufacturer, which the paper discloses. The cognitive and blood-marker results the paper reports are described by its authors as exploratory.
Two older trials: no change in 1998, a small sprint gain in 2001
In the 1998 trial, 32 adults aged 67 to 80 were split into four groups: creatine or placebo, with or without an eight-week strength programme. Creatine alone, with no training, changed no body-composition or strength measure against placebo. The authors concluded that creatine gave no added benefit to healthy older adults, whether or not they trained. The groups were small, eight people each, which limits what a null result can show.
The 2001 trial tested something narrower. It gave five days of creatine, at a higher daily dose than the 1998 maintenance phase, to sedentary and trained older men and to young sedentary men, then measured repeated all-out sprints on a cycle ergometer. The sedentary older men's peak power rose 3.7% and the sedentary young men's 2.0%. The trained older cyclists showed no significant change. The authors' reading is that the level of activity decided whether creatine helped. A sprint test is not a measure of daily function, and the trial did not test one.
What training adds, by comparison
The 2016 drop-set trial did not test creatine alone. It gave 31 untrained adults aged about 58 twelve weeks of resistance training with either creatine or placebo. Creatine added to the training increased muscle mass more than placebo did, and the authors report a larger gain in men than in women. The contrast with the 2026 result is the point: the trials that found a lean-mass effect of creatine in older adults mostly had a training programme running alongside it. The people who do not train are the group these trials cover least.
What is not established
- Whether a lean-mass gain of about a kilogram over 12 weeks changes strength, walking, falls or independence. None of the three trials measured function in a way that answers that.
- Whether the 2026 result holds in trials longer than 12 weeks, or in sedentary people over 65 with the same design.
- Whether creatine alone changes muscle quality, not only DXA lean mass. Lean mass by DXA does not separate muscle from water and other tissue.
- Whether the cognitive findings in the 2026 trial are real. The authors call them exploratory.
Who should ask a clinician first
Anyone with kidney disease, anyone taking medicines that affect the kidneys, and anyone who is pregnant or breastfeeding is in a group that these trials did not study as a group. The site's pages on creatine and kidneys and how creatine fits with existing prescriptions set out what the record covers. The trials on this page report amounts and results; they do not say whether a given person should take creatine.
Related pages
The trials for older adults who train, with the same populations, are on creatine for older adults. The exercise-recovery trials are on creatine for recovery. For what creatine is generally studied for, see creatine benefits, and for the side-effect record, creatine side effects. For how long the trials took to show a change, see how long creatine takes to work.
Sources and dates
- Chun J, Liu Y, Kibler GL, et al. Effects of creatine supplementation with and without exercise and diet intervention on body composition, cognitive function, and markers of health in middle-aged and older adults. J Int Soc Sports Nutr. 2026;23(sup1):2716273. PubMed 42578920. Opened 2026-11-09. Registration ISRCTN83081058.
- Bermon S, Venembre P, Sachet C, et al. Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physiol Scand. 1998;164(2):147-155. PubMed 9805101. Opened 2026-11-09.
- Wiroth JB, Bermon S, Andreï S, et al. Effects of oral creatine supplementation on maximal pedalling performance in older adults. Eur J Appl Physiol. 2001;84(6):533-539. PubMed 11482548. Opened 2026-11-09.
- Johannsmeyer S, Candow DG, Brahms CM, Michel D, Zello GA. Effect of creatine supplementation and drop-set resistance training in untrained aging adults. Exp Gerontol. 2016;83:112-119. PubMed 27523919. Opened 2026-11-09.
- All four trials were read from their PubMed abstracts. The 2026 trial's results paragraphs were also read in its full text (PMC13463452). Sample sizes, dose schedules and conflict statements are as printed in those sources.
